CVRx (CVRX) Total Non-Current Liabilities (2020 - 2026)
CVRx (CVRX) posted Total Non-Current Liabilities of $70.1 million for Q2 2026, up 2.37% on a QoQ basis from $68.5 million in Q1 2026, and up 17.1% year-over-year from $59.9 million in Q2 2025.
Analysis
CVRx (CVRX) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
CVRx has reported Total Non-Current Liabilities for 7 years, with the latest figure at $70.1 million in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 17.1% year-over-year to $70.1 million in Q2 2026; TTM through Jun 2026 was $70.1 million, a 17.1% increase from a year earlier, with the FY2025 full-year figure at $63.5 million, up 4.2% from the prior year.
- Total Non-Current Liabilities was $70.1 million for Q2 2026 at CVRx, up from $68.5 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $70.1 million in Q2 2026, with the low at $6.2 million in Q2 2022.
- Average Total Non-Current Liabilities over 5 years is $40.3 million, with a median of $39.1 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities sank 85.72% in 2022, then surged 291.69% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $15.0 million in 2022, then jumped by 155.79% to $38.2 million in 2023, then soared by 59.26% to $60.9 million in 2024, then grew by 4.2% to $63.5 million in 2025, then rose by 10.52% to $70.1 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $70.1 million (Q2 2026), $68.5 million (Q1 2026), and $63.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.44 Bn |
| 10 | CVRx | 75.57 Mn | 10.98 Mn | 13.72 Mn | 70.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70.14 Mn |
| Mar 31, 2026 | 68.52 Mn |
| Dec 31, 2025 | 63.47 Mn |
| Sep 30, 2025 | 61.40 Mn |
| Jun 30, 2025 | 59.90 Mn |
| Mar 31, 2025 | 58.64 Mn |
| Dec 31, 2024 | 60.91 Mn |
| Sep 30, 2024 | 61.11 Mn |
| Jun 30, 2024 | 39.47 Mn |
| Mar 31, 2024 | 38.76 Mn |
| Dec 31, 2023 | 38.25 Mn |
| Sep 30, 2023 | 22.62 Mn |
| Jun 30, 2023 | 24.12 Mn |
| Mar 31, 2023 | 22.23 Mn |
| Dec 31, 2022 | 14.95 Mn |
| Sep 30, 2022 | 7.57 Mn |
| Jun 30, 2022 | 6.16 Mn |
| Mar 31, 2022 | 6.90 Mn |
| Dec 31, 2021 | 5.91 Mn |
| Sep 30, 2021 | 25.00 Mn |